We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATEC icon
2701
Alphatec Holdings
ATEC
$1.48B
$716K ﹤0.01%
100,853
+2,966
+3% +$19K
SFST icon
2702
Southern First Bancshares
SFST
$601M
$715K ﹤0.01%
16,807
SMMF
2703
DELISTED
Summit Financial Group, Inc.
SMMF
$714K ﹤0.01%
26,327
HBCP icon
2704
Home Bancorp
HBCP
$565M
$713K ﹤0.01%
18,183
DLTH icon
2705
Duluth Holdings
DLTH
$154M
$710K ﹤0.01%
67,355
+821
+1% +$7.65K
MCBC
2706
DELISTED
Macatawa Bank Corp
MCBC
$705K ﹤0.01%
63,279
+2,381
+4% +$25.4K
VNTR
2707
DELISTED
Venator Materials PLC
VNTR
$703K ﹤0.01%
183,384
+3,280
+2% +$10.7K
TBIO
2708
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$702K ﹤0.01%
86,176
+11,846
+16% +$109K
CALA
2709
DELISTED
Calithera Biosciences, Inc
CALA
$701K ﹤0.01%
6,136
+713
+13% +$53.6K
TSBK icon
2710
Timberland Bancorp
TSBK
$353M
$698K ﹤0.01%
23,444
-2,870
-11% -$80.3K
GRBK icon
2711
Green Brick Partners
GRBK
$3.09B
$691K ﹤0.01%
60,180
+2,632
+5% +$28.7K
MCFT icon
2712
MasterCraft Boat Holdings
MCFT
$605M
$690K ﹤0.01%
43,750
APYX icon
2713
Apyx Medical
APYX
$131M
$687K ﹤0.01%
81,185
+3,281
+4% +$23.7K
TLYS icon
2714
Tilly's
TLYS
$130M
$683K ﹤0.01%
55,677
+1,850
+3% +$19.6K
CMLS
2715
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$678K ﹤0.01%
38,543
+2,088
+6% +$32K
AOSL icon
2716
Alpha and Omega Semiconductor
AOSL
$1.04B
$677K ﹤0.01%
49,649
+1,906
+4% +$24.1K
CCRD
2717
DELISTED
CoreCard
CCRD
$676K ﹤0.01%
16,914
+500
+3% +$21.7K
CSLT
2718
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$675K ﹤0.01%
507,249
+5,582
+1% +$7.79K
CVM icon
2719
CEL-SCI Corp
CVM
$26.6M
$674K ﹤0.01%
2,455
MNOV icon
2720
MediciNova
MNOV
$65M
$671K ﹤0.01%
99,434
+3,327
+3% +$25K
HARP
2721
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$668K ﹤0.01%
4,516
+44
+1% +$6.67K
STSA
2722
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$660K ﹤0.01%
+33,515
New +$476K
BRG
2723
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$656K ﹤0.01%
54,376
GNTY
2724
DELISTED
Guaranty Bancshares
GNTY
$654K ﹤0.01%
21,877
FCBP
2725
DELISTED
First Choice Bancorp Common Stock
FCBP
$651K ﹤0.01%
24,132
+834
+4% +$19.2K

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.